$34.46
-0.32-0.92%
At close: -
$34.46
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Xenon Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:XENE | Benzinga
Xenon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.840
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Xenon Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals | -$0.62 | -$0.84 | — | — | $0.00 | — | — | — | 05/08/2025 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.64 | -$0.84 | -$0.84 | 0.00% | $0.00 | $312.50K | $0.00 | -100.00% | 02/27/2025 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.73 | -$0.81 | -$0.81 | 0.00% | $0.00 | — | $0.00 | — | 11/12/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.72 | -$0.70 | -$0.75 | -7.14% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.63 | -$0.66 | -$0.62 | 6.06% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.57 | -$0.76 | -$0.64 | 15.79% | $0.00 | $1.89M | $0.00 | -100.00% | 02/29/2024 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.57 | -$0.77 | -$0.73 | 5.19% | $132.00K | $1.45M | $0.00 | -100.00% | 11/08/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.55 | -$0.70 | -$0.72 | -2.86% | $536.00K | $400.00K | $0.00 | -100.00% | 08/09/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.35 | -$0.62 | -$0.63 | -1.61% | $8.77M | $570.00K | $0.00 | -100.00% | 05/09/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.48 | -$0.58 | -$0.57 | 1.72% | $3.74M | $2.28M | $0.00 | -100.00% | 03/01/2023 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.36 | -$0.52 | -$0.57 | -9.62% | $8.12M | $3.02M | $132.00K | -95.63% | 11/08/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.51 | -$0.48 | -$0.55 | -14.58% | $2.22M | $3.55M | $536.00K | -84.90% | 08/09/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.42 | -$0.41 | -$0.35 | 14.63% | $4.36M | $8.70M | $8.77M | 0.76% | 05/10/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.34 | -$0.37 | -$0.48 | -29.73% | $5.15M | $4.97M | $3.74M | -24.81% | 03/01/2022 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.25 | -$0.38 | -$0.36 | 5.26% | $6.55M | $10.22M | $8.12M | -20.51% | 11/10/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | $0.00 | -$0.48 | -$0.51 | -6.25% | $13.38M | $2.33M | $2.22M | -4.81% | 08/11/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.22 | -$0.40 | -$0.42 | -5.00% | $7.08M | $5.15M | $4.36M | -15.38% | 05/11/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.41 | -$0.40 | -$0.34 | 15.00% | $3.33M | $3.22M | $5.15M | 59.94% | 03/01/2021 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.33 | -$0.15 | -$0.25 | -66.67% | $3.50M | $10.06M | $6.55M | -34.85% | 11/05/2020 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.37 | -$0.24 | $0.00 | 100.00% | $0.00 | $6.90M | $13.38M | 93.97% | 08/06/2020 | Get Alert |
| XENE | Xenon Pharmaceuticals | -$0.42 | -$0.32 | -$0.22 | 31.25% | $0.00 | $4.50M | $7.08M | 57.29% | 05/21/2020 | Get Alert |
Xenon Pharmaceuticals (XENE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.84 | $-0.84 | 0.00 % |
| Q3 | 2024-11-12 | $-0.81 | $-0.81 | 0.00 % |
| Q2 | 2024-08-08 | $-0.75 | $-0.70 | -7.14 % |
| Q1 | 2024-05-09 | $-0.62 | $-0.66 | 6.06 % |
Xenon Pharmaceuticals (XENE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0 | $312.50K | -100.0 % |
| Q4 | 2024-02-29 | $0 | $1.89M | -100.0 % |
| Q3 | 2023-11-08 | $0 | $1.45M | -100.0 % |
| Q2 | 2023-08-09 | $0 | $400.00K | -100.0 % |
FAQ
When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?
Xenon Pharmaceuticals (XENE) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Xenon Pharmaceuticals (NASDAQ:XENE)?
The Actual EPS was $-0.84, which hit the estimate of $-0.84.
What were Xenon Pharmaceuticals’s (NASDAQ:XENE) revenues?
The Actual Revenue was $0K, which missed the estimate of $312.5K.
Browse earnings estimates, EPS, and revenue on all stocks.